Earnings
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
Microbix Biosystems Inc., a life sciences innovator making critical ingredients that enable the production of clinical diagnostics and creating medical devices that help ensure test accuracy, announces that it has completed a non-brokered private placement financing with gross proceeds of $2,355,000, by issuing an aggregate of 11,775,000 units at a price of $0.20 per Unit.
Corteva, Inc. reported financial results for the quarter ended December 31, 2019 and the full year 2019.
Sensyne Health plc, the British Clinical AI technology company, announces its Interim Results for the 6 months ended 31 October 2019.
Parnell announces 2019 year-to-date revenue growth of 9% over the first 9 months of 2018, start of work on its new 2019 CMO contract, and updates to 2019 financial results.
Summit Therapeutics plc reports its financial results and provides an update on its operational progress for the third quarter and nine months ended 31 October 2019.
Vivoryon Therapeutics AG, announced its third quarter business update for the period ending September 30, 2019.
SkinBioTherapeutics has announced its full year results and released details of its strengthened board and management team following the appointment of Stuart Ashman CEO.
Mesoblast Limited reported operational highlights and financial results for the first quarter ended September 30, 2019.
Medexus Pharmaceuticals Inc. announced that it plans to host a conference call at 8:00 AM Eastern Time on Monday, December 2, 2019 to discuss the Company’s financial results for the second quarter ended September 30, 2019, as well as the Company’s corporate progress and other developments.
PRESS RELEASES